“…Later epidemiological studies reflected a high prevalence of T2DM in schizophrenia (Mitchell et al, 2013), bipolar disorder (Calkin et al, 2013) or major depressive disorder (Roy and Lloyd, 2012) although those results might have been confounded by treatment. However, research in treatment-naïve patients found metabolic abnormalities at the onset of mental disorder, in non-affective psychosis (Fernandez-Egea et al, 2009a; Ryan et al, 2003; Saddichha et al, 2008; Spelman et al, 2007) as well as bipolar (Garcia-Rizo et al, 2014b) or major depression disorder (Garcia-Rizo et al, 2013). …”